Suppr超能文献

男性慢性阻塞性肺疾病患者基线参数与第 0 年和第 1 年急性加重的相关性。

Association of baseline parameters with year 0 and year 1 acute exacerbations in male patients with chronic obstructive pulmonary disease.

机构信息

Department of Internal Medicine, 63328Chang Gung Memorial Hospital Kaohsiung Medical Center, Kaohsiung, Taiwan.

Department of Respiratory Therapy, 63328Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.

出版信息

Int J Immunopathol Pharmacol. 2022 Jan-Dec;36:3946320221099073. doi: 10.1177/03946320221099073.

Abstract

OBJECTIVES

Acute exacerbations (AEs) of chronic obstructive pulmonary disease (COPD) can affect health status, hospitalization and readmission rates, and disease progression. This study aimed to identify independent markers associated with COPD AEs.

METHODS

This study included male patients with COPD and collected data regarding their AEs and baseline clinical parameters.

RESULTS

We included 149 male patients. Among them, 58 were included in the year 0 high-AE group and 91 in the low-AE group. Multivariate analysis revealed that the high-AE group had higher white blood cell count, lower serum albumin level, and post-bronchodilator (BD) forced expiratory volume in one second (FEV) (%) with a combined receiver operating characteristic curve (ROC) of 0.721 ( < 0.001). Additionally, 34 patients were included in the year 1 high-AE group and 70 in the low-AE group ( < 0.001). Multivariate analysis revealed that the high-AE group had higher platelet count, positive asthma history, and lower pre-BD FEV (%) with a combined ROC of 0.782 ( < 0.001).

CONCLUSION

In male patients with COPD, baseline white blood cell count, albumin level, and post-BD FEV (%) were correlated with year 0 AE; on the other hand, baseline platelet count, positive asthma history, and pre-BD FEV (%) were associated with year 1 AE.

摘要

目的

慢性阻塞性肺疾病(COPD)的急性加重(AE)可影响健康状况、住院和再入院率以及疾病进展。本研究旨在确定与 COPD AE 相关的独立标志物。

方法

本研究纳入了男性 COPD 患者,并收集了他们的 AE 及基线临床参数数据。

结果

共纳入 149 名男性患者。其中,58 名患者纳入第 0 年高 AE 组,91 名患者纳入低 AE 组。多变量分析显示,高 AE 组的白细胞计数较高,血清白蛋白水平较低,支气管扩张剂后(BD)一秒用力呼气量(FEV)%较低,联合受试者工作特征曲线(ROC)为 0.721(<0.001)。此外,34 名患者纳入第 1 年高 AE 组,70 名患者纳入低 AE 组(<0.001)。多变量分析显示,高 AE 组的血小板计数较高、有哮喘阳性史、BD 前 FEV(%)较低,联合 ROC 为 0.782(<0.001)。

结论

在男性 COPD 患者中,基线白细胞计数、白蛋白水平和 BD 后 FEV(%)与第 0 年 AE 相关;另一方面,基线血小板计数、哮喘阳性史和 BD 前 FEV(%)与第 1 年 AE 相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f0c/9251822/1de470e0ee32/10.1177_03946320221099073-fig1.jpg

相似文献

1
Association of baseline parameters with year 0 and year 1 acute exacerbations in male patients with chronic obstructive pulmonary disease.
Int J Immunopathol Pharmacol. 2022 Jan-Dec;36:3946320221099073. doi: 10.1177/03946320221099073.
3
Impact of exacerbations on adherence and outcomes of pulmonary rehabilitation in patients with COPD.
Respirology. 2017 Jul;22(5):942-949. doi: 10.1111/resp.12987. Epub 2017 Jan 31.
4
Prediction of first acute exacerbation using COPD subtypes identified by cluster analysis.
Int J Chron Obstruct Pulmon Dis. 2019 Jun 28;14:1389-1397. doi: 10.2147/COPD.S205517. eCollection 2019.
5
Physical activity and the frequency of acute exacerbations in patients with chronic obstructive pulmonary disease.
Lung. 2015 Feb;193(1):63-70. doi: 10.1007/s00408-014-9673-7. Epub 2014 Dec 13.
8
Asthma-like Features and Clinical Course of Chronic Obstructive Pulmonary Disease. An Analysis from the Hokkaido COPD Cohort Study.
Am J Respir Crit Care Med. 2016 Dec 1;194(11):1358-1365. doi: 10.1164/rccm.201602-0353OC.
10
Impact of exacerbations on respiratory system impedance measured by a forced oscillation technique in COPD: a prospective observational study.
Int J Chron Obstruct Pulmon Dis. 2017 Feb 3;12:509-516. doi: 10.2147/COPD.S124828. eCollection 2017.

本文引用的文献

1
Healthcare, Medication Utilization and Outcomes of Patients with COPD by GOLD Classification in England.
Int J Chron Obstruct Pulmon Dis. 2021 Sep 15;16:2591-2604. doi: 10.2147/COPD.S318969. eCollection 2021.
2
Biomarkers as a Prognostic Factor in COPD Exacerbation: A Cohort Study.
COPD. 2021 Jun;18(3):325-332. doi: 10.1080/15412555.2021.1922370. Epub 2021 May 10.
3
The Combination of Hemogram Indexes to Predict Exacerbation in Stable Chronic Obstructive Pulmonary Disease.
Front Med (Lausanne). 2020 Dec 9;7:572435. doi: 10.3389/fmed.2020.572435. eCollection 2020.
4
Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort.
Eur Respir J. 2021 Mar 25;57(3). doi: 10.1183/13993003.01339-2020. Print 2021 Mar.
5
Biomarkers in Chronic Obstructive Pulmonary Disease: The Gateway to Precision Medicine.
Clin Chest Med. 2020 Sep;41(3):383-394. doi: 10.1016/j.ccm.2020.06.001.
6
Acute exacerbations of chronic obstructive pulmonary disease: in search of diagnostic biomarkers and treatable traits.
Thorax. 2020 Jun;75(6):520-527. doi: 10.1136/thoraxjnl-2019-214484. Epub 2020 Mar 26.
7
The Acute COPD Exacerbation Prediction Tool (ACCEPT): a modelling study.
Lancet Respir Med. 2020 Oct;8(10):1013-1021. doi: 10.1016/S2213-2600(19)30397-2. Epub 2020 Mar 13.
8
Prognostic value of platelet and neutrophil to lymphocyte ratio in COPD patients.
Expert Rev Respir Med. 2020 Jan;14(1):111-116. doi: 10.1080/17476348.2019.1675517. Epub 2019 Oct 13.
9
Serum Biomarkers in Patients with Stable and Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Comparative Study.
J Med Biochem. 2019 Jan 22;38(4):503-511. doi: 10.2478/jomb-2018-0050. eCollection 2019 Oct.
10
The Asthma-COPD Overlap Syndrome.
Fed Pract. 2015 Sep;32(Suppl 10):19S-23S.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验